Atopic Dermatitis (AD) trial is the second KT-474 Phase 2 clinical trial to begin enrolling patients this quarter following trial…
Health Information Sharing and Analysis Center (Health-ISAC) Thanks Departing Board Member and Welcomes New Board Member From GermanyORMOND BEACH, FL…
"Liquid PDO Threads" suspended in hyaluronic acid in combination with energy-based devices offer superior results. MAX-imize hydration, elasticity, texture, and…
To register for the webinar, click hereSAN FRANCISCO, CA / ACCESSWIRE / December 7, 2023 / Napo Pharmaceuticals (Napo), a…
Beginning Dec. 18, iLet users will have the option of using a Dexcom G7 CGM System.CONCORD, MA / ACCESSWIRE /…
The Company's ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to…
LONDON, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient…
WALTHAM, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the…
Monaghan Medical Corporation Partners with Plattsburgh Community: $100,000 Donation Sparks Vitality in New YMCA Project with Doubling Effect through Anonymous…
MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial MC2-25 CKD is a first-in-class drug…